Could tau-PET imaging contribute to a better understanding of the different patterns of clinical progression in Alzheimer’s disease? A 2-year longitudinal study

Abstract Background Monitoring the progression of Tau pathology makes it possible to study the clinical diversity of Alzheimer’s disease. In this 2-year longitudinal PET study, we aimed to determine the progression of [18F]-flortaucipir binding and of cortical atrophy, and their relationships with c...

Full description

Bibliographic Details
Main Authors: Julien Lagarde, Pauline Olivieri, Matteo Tonietto, Sébastian Rodrigo, Philippe Gervais, Fabien Caillé, Martin Moussion, Michel Bottlaender, Marie Sarazin
Format: Article
Language:English
Published: BMC 2023-05-01
Series:Alzheimer’s Research & Therapy
Subjects:
Online Access:https://doi.org/10.1186/s13195-023-01237-2
_version_ 1797832134671466496
author Julien Lagarde
Pauline Olivieri
Matteo Tonietto
Sébastian Rodrigo
Philippe Gervais
Fabien Caillé
Martin Moussion
Michel Bottlaender
Marie Sarazin
author_facet Julien Lagarde
Pauline Olivieri
Matteo Tonietto
Sébastian Rodrigo
Philippe Gervais
Fabien Caillé
Martin Moussion
Michel Bottlaender
Marie Sarazin
author_sort Julien Lagarde
collection DOAJ
description Abstract Background Monitoring the progression of Tau pathology makes it possible to study the clinical diversity of Alzheimer’s disease. In this 2-year longitudinal PET study, we aimed to determine the progression of [18F]-flortaucipir binding and of cortical atrophy, and their relationships with cognitive decline. Methods Twenty-seven AD patients at the mild cognitive impairment/mild dementia stages and twelve amyloid-negative controls underwent a neuropsychological assessment, 3 T brain MRI, and [18F]-flortaucipir PET imaging (Tau1) and were monitored annually over 2 years with a second brain MRI and tau-PET imaging after 2 years (Tau2). We analyzed the progression of tau standardized uptake value ratio (SUVr) and grey matter atrophy both at the regional and voxelwise levels. We used mixed effects models to explore the relations between the progression of SUVr values, cortical atrophy, and cognitive decline. Results We found an average longitudinal increase in tau SUVr values, except for the lateral temporoparietal cortex where the average SUVr values decreased. Individual analyses revealed distinct profiles of SUVr progression according to temporoparietal Tau1 uptake: high-Tau1 patients demonstrated an increase in SUVr values over time in the frontal lobe, but a decrease in the temporoparietal cortex and a rapid clinical decline, while low-Tau1 patients displayed an increase in SUVr values in all cortical regions and a slower clinical decline. Cognitive decline was strongly associated with the progression of regional cortical atrophy, but only weakly associated with SUVr progression. Conclusions Despite a relatively small sample size, our results suggest that tau-PET imaging could identify patients with a potentially “more aggressive” clinical course characterized by high temporoparietal Tau1 SUVr values and a rapid clinical progression. In these patients, the paradoxical decrease in temporoparietal SUVr values over time could be due to the rapid transition to ghost tangles, for which the affinity of the radiotracer is lower. They could particularly benefit from future therapeutic trials, the neuroimaging outcome measures of which deserve to be discussed.
first_indexed 2024-04-09T14:03:59Z
format Article
id doaj.art-0ad53e566d6a402ab083f0d09cdcccb5
institution Directory Open Access Journal
issn 1758-9193
language English
last_indexed 2024-04-09T14:03:59Z
publishDate 2023-05-01
publisher BMC
record_format Article
series Alzheimer’s Research & Therapy
spelling doaj.art-0ad53e566d6a402ab083f0d09cdcccb52023-05-07T11:07:55ZengBMCAlzheimer’s Research & Therapy1758-91932023-05-0115111210.1186/s13195-023-01237-2Could tau-PET imaging contribute to a better understanding of the different patterns of clinical progression in Alzheimer’s disease? A 2-year longitudinal studyJulien Lagarde0Pauline Olivieri1Matteo Tonietto2Sébastian Rodrigo3Philippe Gervais4Fabien Caillé5Martin Moussion6Michel Bottlaender7Marie Sarazin8Department of Neurology of Memory and Language, GHU Paris Psychiatrie & Neurosciences, Hôpital Sainte AnneDepartment of Neurology of Memory and Language, GHU Paris Psychiatrie & Neurosciences, Hôpital Sainte AnneUniversité Paris-Saclay, BioMaps, Service Hospitalier Frédéric Joliot CEA, CNRSUniversité Paris-Saclay, BioMaps, Service Hospitalier Frédéric Joliot CEA, CNRSUniversité Paris-Saclay, BioMaps, Service Hospitalier Frédéric Joliot CEA, CNRSUniversité Paris-Saclay, BioMaps, Service Hospitalier Frédéric Joliot CEA, CNRSDepartment of Neurology of Memory and Language, GHU Paris Psychiatrie & Neurosciences, Hôpital Sainte AnneUniversité Paris-Saclay, BioMaps, Service Hospitalier Frédéric Joliot CEA, CNRSDepartment of Neurology of Memory and Language, GHU Paris Psychiatrie & Neurosciences, Hôpital Sainte AnneAbstract Background Monitoring the progression of Tau pathology makes it possible to study the clinical diversity of Alzheimer’s disease. In this 2-year longitudinal PET study, we aimed to determine the progression of [18F]-flortaucipir binding and of cortical atrophy, and their relationships with cognitive decline. Methods Twenty-seven AD patients at the mild cognitive impairment/mild dementia stages and twelve amyloid-negative controls underwent a neuropsychological assessment, 3 T brain MRI, and [18F]-flortaucipir PET imaging (Tau1) and were monitored annually over 2 years with a second brain MRI and tau-PET imaging after 2 years (Tau2). We analyzed the progression of tau standardized uptake value ratio (SUVr) and grey matter atrophy both at the regional and voxelwise levels. We used mixed effects models to explore the relations between the progression of SUVr values, cortical atrophy, and cognitive decline. Results We found an average longitudinal increase in tau SUVr values, except for the lateral temporoparietal cortex where the average SUVr values decreased. Individual analyses revealed distinct profiles of SUVr progression according to temporoparietal Tau1 uptake: high-Tau1 patients demonstrated an increase in SUVr values over time in the frontal lobe, but a decrease in the temporoparietal cortex and a rapid clinical decline, while low-Tau1 patients displayed an increase in SUVr values in all cortical regions and a slower clinical decline. Cognitive decline was strongly associated with the progression of regional cortical atrophy, but only weakly associated with SUVr progression. Conclusions Despite a relatively small sample size, our results suggest that tau-PET imaging could identify patients with a potentially “more aggressive” clinical course characterized by high temporoparietal Tau1 SUVr values and a rapid clinical progression. In these patients, the paradoxical decrease in temporoparietal SUVr values over time could be due to the rapid transition to ghost tangles, for which the affinity of the radiotracer is lower. They could particularly benefit from future therapeutic trials, the neuroimaging outcome measures of which deserve to be discussed.https://doi.org/10.1186/s13195-023-01237-2Alzheimer’s diseasePETMRITauopathy
spellingShingle Julien Lagarde
Pauline Olivieri
Matteo Tonietto
Sébastian Rodrigo
Philippe Gervais
Fabien Caillé
Martin Moussion
Michel Bottlaender
Marie Sarazin
Could tau-PET imaging contribute to a better understanding of the different patterns of clinical progression in Alzheimer’s disease? A 2-year longitudinal study
Alzheimer’s Research & Therapy
Alzheimer’s disease
PET
MRI
Tauopathy
title Could tau-PET imaging contribute to a better understanding of the different patterns of clinical progression in Alzheimer’s disease? A 2-year longitudinal study
title_full Could tau-PET imaging contribute to a better understanding of the different patterns of clinical progression in Alzheimer’s disease? A 2-year longitudinal study
title_fullStr Could tau-PET imaging contribute to a better understanding of the different patterns of clinical progression in Alzheimer’s disease? A 2-year longitudinal study
title_full_unstemmed Could tau-PET imaging contribute to a better understanding of the different patterns of clinical progression in Alzheimer’s disease? A 2-year longitudinal study
title_short Could tau-PET imaging contribute to a better understanding of the different patterns of clinical progression in Alzheimer’s disease? A 2-year longitudinal study
title_sort could tau pet imaging contribute to a better understanding of the different patterns of clinical progression in alzheimer s disease a 2 year longitudinal study
topic Alzheimer’s disease
PET
MRI
Tauopathy
url https://doi.org/10.1186/s13195-023-01237-2
work_keys_str_mv AT julienlagarde couldtaupetimagingcontributetoabetterunderstandingofthedifferentpatternsofclinicalprogressioninalzheimersdiseasea2yearlongitudinalstudy
AT paulineolivieri couldtaupetimagingcontributetoabetterunderstandingofthedifferentpatternsofclinicalprogressioninalzheimersdiseasea2yearlongitudinalstudy
AT matteotonietto couldtaupetimagingcontributetoabetterunderstandingofthedifferentpatternsofclinicalprogressioninalzheimersdiseasea2yearlongitudinalstudy
AT sebastianrodrigo couldtaupetimagingcontributetoabetterunderstandingofthedifferentpatternsofclinicalprogressioninalzheimersdiseasea2yearlongitudinalstudy
AT philippegervais couldtaupetimagingcontributetoabetterunderstandingofthedifferentpatternsofclinicalprogressioninalzheimersdiseasea2yearlongitudinalstudy
AT fabiencaille couldtaupetimagingcontributetoabetterunderstandingofthedifferentpatternsofclinicalprogressioninalzheimersdiseasea2yearlongitudinalstudy
AT martinmoussion couldtaupetimagingcontributetoabetterunderstandingofthedifferentpatternsofclinicalprogressioninalzheimersdiseasea2yearlongitudinalstudy
AT michelbottlaender couldtaupetimagingcontributetoabetterunderstandingofthedifferentpatternsofclinicalprogressioninalzheimersdiseasea2yearlongitudinalstudy
AT mariesarazin couldtaupetimagingcontributetoabetterunderstandingofthedifferentpatternsofclinicalprogressioninalzheimersdiseasea2yearlongitudinalstudy